Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice.

Summary

Using induced whole-body LpL deficiency on an LDLR-deficient background, the authors demonstrate that non-remnant, nascent TRLs can drive atherosclerosis in mice fed a Western-type diet. This challenges the remnant-centric view of TRL-driven atherogenesis and implicates lipolysis-independent pathways in vascular injury.

Key Findings

• Induced whole-body LpL deficiency on an LDLR-deficient background generates non-remnant, nascent TRLs in vivo.
• Mice with LpL deficiency developed increased atherosclerosis on a Western-type diet, implicating nascent TRLs as atherogenic.
• Findings challenge the remnant-centric paradigm and point to lipolysis-independent mechanisms in TRL-driven atherogenesis.

Clinical Implications

Although preclinical, these findings suggest that therapies exclusively lowering remnant cholesterol may be insufficient; interventions targeting TRL production, clearance, or lipolysis-independent pathways could be necessary to reduce atherogenic burden.

Limitations

• Preclinical mouse study limits direct generalizability to humans.
• Abstract truncation limits quantitative details on effect sizes and tissue-specific analyses.

Future Directions

Define molecular pathways by which nascent TRLs induce vascular injury, quantify atherogenicity across TRL subclasses, and test pharmacologic interventions targeting TRL biogenesis and clearance in preclinical and early-phase clinical studies.